Royalty Report: Diagnostic, Medical, Drugs – Collection: 6493

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Diagnostic
  • Medical
  • Drugs
  • Disease
  • Biotechnology
  • Diagnostic Substances
  • Pharmaceuticals
  • cardiac

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 6493

License Grant
The Licensee signed the Assignment and Consultation Agreement with a Doctor, with whom the Licensee has collaborated with on the appendicitis products. The Licensee expects that expenditures will be incurred to continue to advance the initial appendicitis blood test technology, AppyScoreâ„¢ through the FDA application and clearance process in addition to advancing development of the next generation appendicitis products.
Field of Use
AppyScore Human Appendicitis Triage Blood Test Licensee progresses in the development and testing of its first-generation blood-based human diagnostic tests designed to rapidly aid in the diagnosis of appendicitis in patients complaining of abdominal pain. Specifically, we have created and optimized a specialized test to detect a marker in the blood associated with appendicitis and have tested this assay in several clinical research trials involving hundreds of human patients.   The  appendicitis triage blood screen test AppyScore,  is based on a blood test result scoring system designed to be used as an initial appendicitis triage or screening test for patients entering an emergency department or urgent care facility complaining of abdominal pain.

IPSCIO Record ID: 6178

License Grant
The Licensee signed the Assignment and Consultation Agreement with an individual who has collaborated on the appendicitis blood test products.
License Property
Technology involves a blood-based test to quickly and accurately assist in diagnosing or ruling out appendicitis.  Appendicitis is a condition characterized by inflammation of the appendix.
Field of Use
The rights granted apply to the medical industry.

IPSCIO Record ID: 338029

License Grant
Licensor hereby grants to Canadian Licensee a license to Licensor’s intellectual property rights, if any, in the POC Rapid Assays, to distribute, use and sell the POC Rapid Assays throughout the world, subject to the terms and conditions of this Agreement.
License Property
POC Rapid Assays shall mean rapid assay diagnostic point of care products, utilizing Reagents; provided, however, that “POC Rapid Assays” shall not include devices for test procedures performed in a hospital’s central clinical laboratory or in a reference laboratory setting. In addition, “POC Rapid Assays” shall not include any assay that can be used on any instrument with random access capability and/or any instrument with the ability to analyze multiple samples.

Reagents shall mean biomarkers and protein targets developed and produced by Licensee for the diagnosis of congestive heart failure, insulin resistance, Alzheimer’s disease, traumatic brain injury and other various diseases, excluding stroke. The term “Reagents” shall also include all other biomarkers and protein targets developed and produced by Licensee (other than for stroke) for which there shall be application in the point of care diagnostic products.

POC Rapid Assay Specifications shall mean the standards and specifications for the manufacture of the POC Rapid Assays, as developed and agreed to by the Parties, as amended from time to time, and shall be appended to and form part of this Agreement.

Reagent Specifications shall mean the standards and specifications for the manufacture of the Reagents, as developed and agreed to by the Parties, as amended from time to time, and shall be appended to and form part of this Agreement.

Field of Use
The biomarkers are used to determine the diagnosis of congestive heart failure, insulin resistance, Alzheimer’s disease, traumatic brain injury and other various diseases, excluding stroke.  Biomarkers can be measured through a blood sample.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.